Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
group | 0.800 | None | 0.960 | 0 | 0 | 2009 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.800 | limited | 0.973 | 0 | 0 | 2009 | 2020 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
group | 0.800 | limited | 0.971 | 0 | 0 | 2011 | 2020 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
group | 0.800 | None | 0.963 | 0 | 0 | 2011 | 2020 | ||||||||
|
SBDS ribosome maturation factor | 0.601 | 0.692 | 6.2E-05 |
|
group | 0.620 | strong | 1.000 | 0 | 0 | 2009 | 2017 | ||||||||
|
zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | 0.751 | 0.231 | 1.00 |
|
group | 0.580 | None | 1.000 | 0 | 0 | 2012 | 2020 | ||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
group | 0.570 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
group | 0.500 | None | 1.000 | 0 | 0 | 2012 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.500 | None | 1.000 | 0 | 0 | 2001 | 2017 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
group | 0.500 | None | 1.000 | 0 | 0 | 1998 | 2020 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
group | 0.420 | None | 1.000 | 0 | 0 | 2015 | 2020 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
group | 0.410 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1990 | 2009 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
group | 0.400 | None | 0.923 | 0 | 0 | 2002 | 2020 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2009 | 2016 | ||||||||
|
Rho GTPase activating protein 26 | 0.656 | 0.500 | 1.00 |
|
group | 0.330 | None | 0.667 | 0 | 0 | 2006 | 2011 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
group | 0.330 | None | 1.000 | 0 | 0 | 2015 | 2019 |